Puma Biotechnology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.About PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer.
PBYI Key Statistics
PBYI News
Last week, you might have seen that Puma Biotechnology, Inc. (NASDAQ:PBYI) released its first-quarter result to the market. The early response was not positive,...
Puma Biotechnology (NASDAQ:PBYI) First Quarter 2024 Results Key Financial Results Revenue: US$43.8m (down 17% from 1Q 2023). Net loss: US$4.80m (down by 443%...
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.0...
More PBYI News
Puma Biotechnology, Inc. PBYI reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of...
Puma Biotech (PBYI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to earnings of $0.09...
Revenue: Reported at $43.8 million, exceeding estimates of $41.05 million. Net Loss: Posted a net loss of $4.8 million, significantly better than the estimated...
LOS ANGELES, May 02, 2024--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the first quar...
Net cash provided by operating activities for the first quarter of 2024 was $11.3 million, compared to $2.6 million in the first quarter of 2023. At March 31, 2...